138 results
8-K
BCDA
BioCardia Inc.
1 May 24
BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
7:00am
results of the open label roll-in cohort of the CardiAMP® Cell Therapy in Chronic Myocardial Ischemia Trial. The data was presented in a webcast sponsored
8-K
EX-99.1
BCDA
BioCardia Inc.
1 May 24
BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
7:00am
Exhibit 99.1
BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
Sunnyvale … in Chronic Myocardial Ischemia Trial.
Study clinical cardiology leadership and members of the Executive Steering Committee, Dr. Carl Pepine, Professor
8-K
EX-99.1
BCDA
BioCardia Inc.
27 Mar 24
BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results
4:07pm
reimbursement to substantially offset the clinical costs of performing the study.
CardiAMP Autologous Cell Therapy for Chronic Myocardial Ischemia (BCDA-02 … )
The CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial is a Medicare reimbursed Phase III, multi-center, randomized, double-blinded, controlled
8-K
EX-99.1
sknqhydwdf0ey6d
4 Mar 24
Regulation FD Disclosure
8:00am
8-K
5cbh ng7mog
4 Mar 24
Regulation FD Disclosure
8:00am
8-K
EX-99.1
4qnnz3vtjdki0rylo
8 Feb 24
BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDA
7:03am
8-K
EX-99.1
2733t5dt wor
31 Jan 24
BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics Conference
7:00am
8-K
EX-99.1
fxvu9oe5 xeyh2lw9
3 Jan 24
Business Development Update for Shareholders
7:00am
8-K
EX-99.1
qjd058d um2be
19 Dec 23
Other Events
7:00am
8-K
EX-99.1
kylon
18 Dec 23
BioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation Minutes
7:00am
424B5
tusqnxdvfp588
6 Dec 23
Prospectus supplement for primary offering
6:03am
8-K
EX-99.1
celks3gko2 kdj
29 Nov 23
Other Events
7:00am
424B5
64o j0uk6
17 Nov 23
Prospectus supplement for primary offering
5:25pm
8-K
EX-99.1
b7nyt
14 Nov 23
BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure
12:00am
8-K
EX-99.1
db7a7hd175
8 Nov 23
Biocardia Reports Third Quarter 2023 Business Highlights and Financial Results
4:08pm